ETFs & Funds
) agreed to buy Inhibitex (
) for $2.5 billion, but
's market cap is still $1.85 billion.
Add a reply...
Latest StockTalks »
people get BMY breaking news and analysis by email alert.
Get email alerts on BMY »
Bristol-Myers Squibb Company
Get latest price
From other sites
Bristol-Myers (BMY) Beats on Q4 Earnings and Revenues
at Zacks.com (Jan 28, 2016)
Why Bristol-Myers Squibb (BMY) Might Surprise This Earnings Season
at Zacks.com (Jan 27, 2016)
Will Bristol-Myers (BMY) Crush Estimates at Its Next Earnings Report?
at Zacks.com (Dec 10, 2015)
Bristol Myers Squibb : New Longer-Term Data for Empliciti (elotuzumab) Showed a Continued Progression-Free Survival Benefit in Patients with Relapsed or Refractory Multiple Myeloma
at 4-traders.com (Dec 5, 2015)
Why Bristol-Myers Squibb is a Top 25 Dividend Giant (BMY)
at Nasdaq.com (Nov 12, 2015)